These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19433749)

  • 41. Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease.
    Gil V; Nicolas O; Mingorance A; Ureña JM; Tang BL; Hirata T; Sáez-Valero J; Ferrer I; Soriano E; del Río JA
    J Neuropathol Exp Neurol; 2006 May; 65(5):433-44. PubMed ID: 16772867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures.
    Craveiro LM; Hakkoum D; Weinmann O; Montani L; Stoppini L; Schwab ME
    Eur J Neurosci; 2008 Nov; 28(9):1808-24. PubMed ID: 18973596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Preparation and identification of rabbit antibody against LRR of Nogo-66 receptor (NgR)].
    Yu PP; Zhu HQ; Lu PH; Huang LD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):633-5. PubMed ID: 16948913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antibodies against encephalitogenic protein and myelin glycoprotein in the cerebrospinal fluid of patients with multiple sclerosis. Effect of encorton treatment on the autoantibody and immune complex levels].
    Waigt A; Górny MK
    Folia Med Cracov; 1984; 25(3-4):307-18. PubMed ID: 6085729
    [No Abstract]   [Full Text] [Related]  

  • 45. Do myelin-directed antibodies predict multiple sclerosis?
    Antel JP; Bar-Or A
    N Engl J Med; 2003 Jul; 349(2):107-9. PubMed ID: 12853581
    [No Abstract]   [Full Text] [Related]  

  • 46. Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.
    Teunissen CE; Tumani HT; Bennett JL; Berven FS; Brundin L; Comabella M; Franciotta D; Federiksen JL; Fleming JO; Furlan R; Hintzen RQ; Hughes SG; Johnson MH; Krasulova E; Kuhle J; Magnone MC; Petzold A; Rajda C; Rejdak K; Schmidt HK; van Pesch V; Waubant E; Wolf C; Hemmer B; Deisenhammer F; Giovannoni G
    Mult Scler; 2010 Feb; 16(2):129-32. PubMed ID: 20042453
    [No Abstract]   [Full Text] [Related]  

  • 47. Cystatin C in cerebrospinal fluid and multiple sclerosis.
    Hansson SF; Simonsen AH; Zetterberg H; Andersen O; Haghighi S; Fagerberg I; Andréasson U; Westman-Brinkmalm A; Wallin A; Rüetschi U; Blennow K
    Ann Neurol; 2007 Aug; 62(2):193-6; discussion 205. PubMed ID: 16900522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelin basic protein: what role in MS?
    JAMA; 1978 Jul; 240(1):15. PubMed ID: 77920
    [No Abstract]   [Full Text] [Related]  

  • 49. Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.
    Ayoglu B; Häggmark A; Khademi M; Olsson T; Uhlén M; Schwenk JM; Nilsson P
    Mol Cell Proteomics; 2013 Sep; 12(9):2657-72. PubMed ID: 23732997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
    Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
    Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunology of multiple sclerosis.
    Olsson T
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):195-202. PubMed ID: 1623247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CSF analysis in suspected MS: do bands aid?
    Hintzen RQ; Giovannoni G
    Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264
    [No Abstract]   [Full Text] [Related]  

  • 53. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library.
    Yu X; Gilden DH; Ritchie AM; Burgoon MP; Keays KM; Owens GP
    J Neuroimmunol; 2006 Mar; 172(1-2):121-31. PubMed ID: 16371235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular features of immunoreactive myelin basic protein in cerebrospinal fluid of persons with multiple slcerosis.
    Bashir RM; Whitaker JN
    Ann Neurol; 1980 Jan; 7(1):50-7. PubMed ID: 6153878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimyelin antibody in multiple sclerosis: no change during immunosuppression.
    Wilkerson LD; Lisak RP; Zweiman B; Silberberg DH
    J Neurol Neurosurg Psychiatry; 1977 Sep; 40(9):872-5. PubMed ID: 599363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury.
    Palfreyman JW; Thomas DG; Ratcliffe JG
    Clin Chim Acta; 1978 Jan; 82(3):259-70. PubMed ID: 563780
    [No Abstract]   [Full Text] [Related]  

  • 57. Abstracts of workshop on cellular and humoral components of CSF in multiple sclerosis. NATO advanced research workshop. Hengelhoef, Limburg, Belgium, April 20-24, 1986.
    Acta Neurol Belg; 1986; 86(3):170-212. PubMed ID: 3739619
    [No Abstract]   [Full Text] [Related]  

  • 58. Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.
    Abbott RJ; Giles PD; Bolderson I
    J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):102-3. PubMed ID: 3958724
    [No Abstract]   [Full Text] [Related]  

  • 59. When antibodies mislead: the quest for validation.
    Baker M
    Nature; 2020 Sep; 585(7824):313-314. PubMed ID: 32895531
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunological surrogate markers of disease activity in multiple sclerosis.
    Kieseier BC; Giovannoni G; Hartung HP
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():570-83. PubMed ID: 10689511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.